Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions

Macroautophagy, a quality control mechanism, is an evolutionarily conserved pathway of lysosomal degradation of protein aggregates, pathogens, and damaged organelles. As part of its vital homeostatic role, macroautophagy deregulation is associated with various human disorders, including neurodegener...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: João Duarte Magalhães, Lígia Fão, Rita Vilaça, Sandra Morais Cardoso, Ana Cristina Rego
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/6f78b7975de548c9ac8d1c282986a06e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6f78b7975de548c9ac8d1c282986a06e
record_format dspace
spelling oai:doaj.org-article:6f78b7975de548c9ac8d1c282986a06e2021-11-25T16:49:44ZMacroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions10.3390/biomedicines91116252227-9059https://doaj.org/article/6f78b7975de548c9ac8d1c282986a06e2021-11-01T00:00:00Zhttps://www.mdpi.com/2227-9059/9/11/1625https://doaj.org/toc/2227-9059Macroautophagy, a quality control mechanism, is an evolutionarily conserved pathway of lysosomal degradation of protein aggregates, pathogens, and damaged organelles. As part of its vital homeostatic role, macroautophagy deregulation is associated with various human disorders, including neurodegenerative diseases. There are several lines of evidence that associate protein misfolding and mitochondrial dysfunction in the etiology of Alzheimer’s, Parkinson’s, and Huntington’s diseases. Macroautophagy has been implicated in the degradation of different protein aggregates such as Aβ, tau, alpha-synuclein (α-syn), and mutant huntingtin (mHtt) and in the clearance of dysfunctional mitochondria. Taking these into consideration, targeting autophagy might represent an effective therapeutic strategy to eliminate protein aggregates and to improve mitochondrial function in these disorders. The present review describes our current understanding on the role of macroautophagy in neurodegenerative disorders and focuses on possible strategies for its therapeutic modulation.João Duarte MagalhãesLígia FãoRita VilaçaSandra Morais CardosoAna Cristina RegoMDPI AGarticleneurodegenerative disordersautophagymitophagy mitochondrial dysfunctionmutant proteinstherapeutic strategiesBiology (General)QH301-705.5ENBiomedicines, Vol 9, Iss 1625, p 1625 (2021)
institution DOAJ
collection DOAJ
language EN
topic neurodegenerative disorders
autophagy
mitophagy mitochondrial dysfunction
mutant proteins
therapeutic strategies
Biology (General)
QH301-705.5
spellingShingle neurodegenerative disorders
autophagy
mitophagy mitochondrial dysfunction
mutant proteins
therapeutic strategies
Biology (General)
QH301-705.5
João Duarte Magalhães
Lígia Fão
Rita Vilaça
Sandra Morais Cardoso
Ana Cristina Rego
Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions
description Macroautophagy, a quality control mechanism, is an evolutionarily conserved pathway of lysosomal degradation of protein aggregates, pathogens, and damaged organelles. As part of its vital homeostatic role, macroautophagy deregulation is associated with various human disorders, including neurodegenerative diseases. There are several lines of evidence that associate protein misfolding and mitochondrial dysfunction in the etiology of Alzheimer’s, Parkinson’s, and Huntington’s diseases. Macroautophagy has been implicated in the degradation of different protein aggregates such as Aβ, tau, alpha-synuclein (α-syn), and mutant huntingtin (mHtt) and in the clearance of dysfunctional mitochondria. Taking these into consideration, targeting autophagy might represent an effective therapeutic strategy to eliminate protein aggregates and to improve mitochondrial function in these disorders. The present review describes our current understanding on the role of macroautophagy in neurodegenerative disorders and focuses on possible strategies for its therapeutic modulation.
format article
author João Duarte Magalhães
Lígia Fão
Rita Vilaça
Sandra Morais Cardoso
Ana Cristina Rego
author_facet João Duarte Magalhães
Lígia Fão
Rita Vilaça
Sandra Morais Cardoso
Ana Cristina Rego
author_sort João Duarte Magalhães
title Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions
title_short Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions
title_full Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions
title_fullStr Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions
title_full_unstemmed Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions
title_sort macroautophagy and mitophagy in neurodegenerative disorders: focus on therapeutic interventions
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/6f78b7975de548c9ac8d1c282986a06e
work_keys_str_mv AT joaoduartemagalhaes macroautophagyandmitophagyinneurodegenerativedisordersfocusontherapeuticinterventions
AT ligiafao macroautophagyandmitophagyinneurodegenerativedisordersfocusontherapeuticinterventions
AT ritavilaca macroautophagyandmitophagyinneurodegenerativedisordersfocusontherapeuticinterventions
AT sandramoraiscardoso macroautophagyandmitophagyinneurodegenerativedisordersfocusontherapeuticinterventions
AT anacristinarego macroautophagyandmitophagyinneurodegenerativedisordersfocusontherapeuticinterventions
_version_ 1718412902909607936